EPOPROSTENOL SODIUM
Marketedupdated 2mo agoby Janssen-Cilag Holdings Inc (Inactive)
Approvedcommunity read0 votes
all catalysts(1)
News(0)
no news has mentioned this drug yet
no news has mentioned this drug yet
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
comments(0)
5-min edit window · permanent after that